Cargando…
Heterotrimeric G proteins as emerging targets for network based therapy in cancer: End of a long futile campaign striking heads of a Hydra
Most common diseases, e.g., cancer are driven by not one, but multiple cell surface receptors that trigger and sustain a pathologic signaling network. The largest fraction of therapeutic agents that target individual receptors/pathways eventually fail due to the emergence of compensatory mechanisms...
Autor principal: | Ghosh, Pradipta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543036/ https://www.ncbi.nlm.nih.gov/pubmed/26224586 |
Ejemplares similares
-
Autonomy and authority in medical futility
por: Jiang, Zhengyu, et al.
Publicado: (2014) -
On the Futility of Screening for Genes That Make You Fat
por: Veerman, J. Lennert
Publicado: (2011) -
Medical futility in the era of evidence-based medicine
por: Jiang, Zhengyu, et al.
Publicado: (2014) -
Hydra’s Lasting Partnership with Microbes: The Key for Escaping Senescence?
por: He, Jinru, et al.
Publicado: (2022) -
Biomolecular Self-Defense and Futility of High-Specificity Therapeutic Targeting
por: Rosenfeld, Simon
Publicado: (2011)